Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
3Y CAGR+13.3%
5Y CAGR+12.0%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+13.3%/yr
vs +7.4%/yr prior
5Y CAGR
+12.0%/yr
Consistent
Acceleration
+5.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
8 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $363.83M | +1.6% |
| 2024 | $358.11M | +22.1% |
| 2023 | $293.27M | +17.3% |
| 2022 | $250.13M | +5.1% |
| 2021 | $238.03M | +15.3% |
| 2020 | $206.51M | +8.4% |
| 2019 | $190.43M | +1.5% |
| 2018 | $187.68M | +25.6% |
| 2017 | $149.38M | -1.1% |
| 2016 | $150.98M | - |